Adipose tissue mesenchymal stem cells and methods of use to treat or inhibit uterine disorders
AssigneeAvita International Ltd.
InventorIrina Kerkis
Life of this patent
Estimating the term…
Abstract
There is a high stem cell therapy potential in the field of reproductive disorders. Endometriosis is a common finding in women with infertility. In addition endometriosis is the major problem in the veterinary field. In the disclosed invention we provide a method of application and use of adipose tissue derived stem cell to treat fertility and pregnancy related disorders, especially endometriosis in mammalian objects.
Claims34
A method of treating a mammalian female subject having a disorder selected from the group consisting of:
- endometriosis, endometrosis, atypical endometrium, poor endometrium, thin uterine lining, uterine polyps and fibroids, intrauterine adhesions, uterine cavity scar tissue, uterine disorders or injury, uterine related infertility or pregnancy problems, the method comprising transplanting adipose tissue derived mesenchymal stem cells (AT-MSCs) into the uterus of the mammalian female in need thereof.
A composition comprising adipose tissue derived mesenchymal stem cells (AT-MSCs) and a pharmaceutically acceptable carrier, wherein the AT-MSCs are in an amount sufficient to positively regulate uterine tissue integrity and/or function.
Dependencies are inferred from the claim text.